LexDanaLexDanabeta
Inventor

JESSICA LIANG

Inventor
US

Overview

4→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Bprimary
A61BDiagnosis38%
A61FFilters implantable into blood vessels13%
A61KPreparations for medical, dental or toiletry purposes13%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations13%
C07DHeterocyclic compounds13%
C07HSugars13%
PatentTitleYear
12,490,990Vessel occluder202511,832,824Vascular occlusion202311,583,287Vessel occluder2023RE049080Glycoside derivatives and uses thereof2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022Patents assigned to NOVARTIS AG (1)· patent assignee history
2022–2023Based in US· patent location history
2023–2025Patents assigned to TERUMO CORP (3)· patent assignee history
2025Based in JP· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
TERUMO CORP32023–2025
NOVARTIS AG12022
Locations
LocationPatentsSpan
US32022–2023
JP12025